The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients
Abstract
Lipodystrophy patients are hypoleptinemic and insulin resistant. Women have enlarged polycystic ovaries, hyperandrogenism, and amenorrhea. We have determined the role of correction of hypoleptinemia on these metabolic and neuroendocrine parameters. Ten females and 4 males with generalized lipodystrophy were treated with recombinant methionyl human leptin (r-metHuLeptin) in physiologic doses in an open-labeled study for a period of 12 and 8 months, respectively. In the female group, serum free testosterone decreased from 39.6 +/- 11 to 18.9 +/- 4.5 ng/dL (P < 0.01) and serum sex hormone binding globulin increased from 14 +/- 2.5 to 25 +/- 4.8 nmol/L (P < 0.02). Luteinizing hormone (LH) responses to LH releasing hormone were more robust after therapy and significantly changed in the youngest group of 3 female patients (P < 0.01). Ovarian ultrasound showed a polycystic ovarian disease pattern in all patients and did not change after therapy. Eight of the 10 patients had amenorrhea prior to therapy and all 8 developed normal menses after therapy. In the male group, serum testosterone tended to increase from 433 +/- 110 to 725 +/- 184 ng/dL (P = 0.1) and sex hormone binding globulin also increased from 18.25 +/- 2.6 to 27 +/- 1.7 nmol/L (P < 0.04) following r-metHuLeptin therapy. Serum LH response to LH releasing hormone did not show significant changes. Five additional hypoleptinemic male subjects with minimal metabolic abnormalities underwent normal pubertal development without receiving r-metHuLeptin therapy. In both genders, insulin-like growth factor increased significantly and there were no differences in growth hormone, thyroid, or adrenal hormone levels following r-metHuLeptin therapy. Glycemic parameters significantly improved after r-metHuLeptin therapy in both groups. Hypoglycemic medications were discontinued in 7 of 12 patients and dramatically reduced in 5 patients. r-metHuLeptin therapy plays an important role in insulin sensitivity. In females, it plays an additional role in normalizing menstrual function. This is likely to occur both from increasing insulin sensitivity and from restoring LH pulsatility. The persistent hypoleptinemic state in these subjects did not inhibit pubertal development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Female patients generally had hypogonadotropic amenorrhea, as previously described (9,10).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [10]
In the citing paper
“Most female patients resumed and sustained normal menses following initiation of r-metHuLeptin”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [10]
In the citing paper
“consistent with normalization of their gonadotropin axis (9,10).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [10]
In the citing paper
“R-metHuLeptin therapy led to a decrease in serum androgen levels and normal cyclic menses in women of reproductive age (9,10).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [10]
In the citing paper
“R-MetHuLeptin therapy is associated with decreased energy intake, improvements in dyslipidemia, hepatic steatosis, and insulin resistance, as well as hypothalamic regulation of the gonadal axis (9,10).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [10]
In the citing paper
“Treatment with metreleptin also has improved reproductive function in other leptin-de fi cient conditions, including congenital leptin de fi ciency (23) and lipodystrophy (26), in uncontrolled pilot studies.”
From Leptin is an effective treatment for hypothalamic amenorrhea (2011) · cites this paper as [26]
Citations
Cites
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15693 · Cited by 1,374
Self-citationLeptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247 · cited 9×
“The second is acquired and congenital forms of lipodystrophy, characterized by insulin resistance [2], and the third is the Rabson-Mendenhall syndrome with a presumed mutation in the insulin receptor and also characterized by insulin resistance [11].”
BackgroundResultInfluentialSelf-citationInsulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,167
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215693 · Cited by 1,105
Self-citationThe Syndromes of Insulin Resistance and Acanthosis Nigricans
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Görden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,101
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., Sharma, R., Hudgins, L. C., Ntambi, J. M., & Friedman, J. M. (2002) · Science · doi:10.1126/science.1071527 · Cited by 826
Early onset of reproductive function in normal female mice treated with leptin
Chehab, F. F., Mounzih, K., Lu, R., & Lim, M. E. (1997) · Science · doi:10.1126/science.275.5296.88 · Cited by 822
Leptin accelerates the onset of puberty in normal female mice.
Ahima, R. S., Dushay, J. R., Flier, S. N., Prabakaran, D., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119172 · Cited by 760
Cited by
Sorted by citations
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
Park, H. K., & Ahima, R. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.08.004 · Cited by 710
Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
Kelesidis, T., Kelesidis, I., Chou, S. H.-H., & Mantzoros, C. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00008 · Cited by 693
Leptin in Human Physiology and Pathophysiology
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S.-Y., Hamnvik, O.-P. R., & Koniaris, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2011 · Cited by 593
Puberty : ontogeny, neuroendocrinology, physiology, and disorders
Styne, D. M., Grumbach, M. M., Dennis, M., Styne, J., & Melvin, M. N. (1998) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 546
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Brown, R. J., Araújo‐Vilar, D., Cheung, P. T., Dunger, D. B., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2466 · Cited by 540
Brennan, A. M., & Mantzoros, C. S. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0196 · Cited by 374
Michalakis, K., Mintziori, G., Kaprara, A., Tarlatzis, B. C., & Goulis, D. G. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.012 · Cited by 321
Adipokines and the Peripheral and Neural Control of Energy Balance
Ahima, R. S., & Lazar, M. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0529 · Cited by 324
Leptin in human physiology and therapeutics
Dardeno, T. A., Chou, S. H.-H., Moon, H., Chamberland, J. P., Fiorenza, C. G., & Mantzoros, C. S. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.06.002 · Cited by 297
Leptin is an effective treatment for hypothalamic amenorrhea
Chou, S. H., Chamberland, J. P., Liu, X., Matarese, G., Gao, C., Stefanakis, R., Brinkoetter, M. T., Gong, H., Arampatzi, K., & Mantzoros, C. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015674108 · Cited by 287
Congenital generalized lipodystrophies—new insights into metabolic dysfunction
Patni, N., & Garg, A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.123 · Cited by 262
Lipodystrophy: pathophysiology and advances in treatment
Fiorenza, C. G., Chou, S. H.-H., & Mantzoros, C. S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.199 · Cited by 255
Leptin applications in 2015: what have we learned about leptin and obesity?
Farr, O. M., Gavrieli, A., & Mantzoros, C. S. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000184 · Cited by 233
Ebihara, K., Kusakabe, T., Hirata, M., Masuzaki, H., Miyanaga, F., Kobayashi, N., Tanaka, T., Chusho, H., Miyazawa, T., Hayashi, T., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1546 · Cited by 231
Self-citationLong-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy
Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., DePaoli, A. M., & Gorden, P. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1994 · Cited by 226
Self-citationDifferential regulation of metabolic, neuroendocrine, and immune function by leptin in humans.
Chan, J. L., Matarese, G., Shetty, G. K., Raciti, P., Kelesidis, I., Aufiero, D., De Rosa, V., Perna, F., Fontana, S., & Mantzoros, C. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505429103 · Cited by 213
Dalamaga, Μ., Chou, S. H.-H., Shields, K. S., Papageorgiou, P., Pοlyzos, S. A., & Mantzoros, C. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.010 · Cited by 199
Diker‐Cohen, T., Cochran, E. K., Görden, P., & Brown, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4491 · Cited by 181
Self-citationEfficacy of leptin therapy in the different forms of human lipodystrophy
Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Görden, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 175
Self-citationThe effect of underweight on female and male reproduction
Boutari, C., Pappas, P. D., Mintziori, G., Nigdelis, M. P., Athanasiadis, L., Goulis, D. G., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154229 · Cited by 181
Brain Adipocytokine Action and Metabolic Regulation
Ahima, R. S., Qi, Y., Singhal, N. S., Jackson, M. B., & Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-s018 · Cited by 150
Farr, O. M., Tsoukas, M. A., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.004 · Cited by 153
Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
Chan, J. L., Lutz, K., Cochran, E. K., Huang, W., Peters, Y., Weyer, C., & Görden, P. (2011) · Endocrine Practice · doi:10.4158/ep11229.or · Cited by 147
Self-citationThe Use of U-500 in Patients With Extreme Insulin Resistance
Cochran, E. K., Musso, C., & Görden, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1240 · Cited by 138
Self-citationAhima, R. S., & Osei, S. Y. (2008) · Frontiers of hormone research · doi:10.1159/000115365 · Cited by 136
High-dose Insulin Therapy: is it Time for U-500 Insulin?
Lane, W. S., Cochran, E. K., Jackson, J. A., Scism-Bacon, J. L., Corey, I. B., Hirsch, I. B., & Skyler, J. S. (2009) · Endocrine Practice · doi:10.4158/ep.15.1.71 · Cited by 124
Self-citationAdipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 118
Adipose tissue and reproductive health
Mathew, H., Castracane, V. D., & Mantzoros, C. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.11.006 · Cited by 109
20 YEARS OF LEPTIN: Role of leptin in human reproductive disorders
Chou, S. H.-H., & Mantzoros, C. S. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0245 · Cited by 110
Park, J. Y., Javor, E. D., Cochran, E. K., DePaoli, A. M., & Görden, P. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.010 · Cited by 103
Self-citationFertility and Obstetrical Complications in Women withLMNA-Related Familial Partial Lipodystrophy
Vantyghem, M., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A. S., Lascols, O., Hécart, A. C., Pigny, P., Delemer, B., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2521 · Cited by 98
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 96
Metabolic Fuel and Clinical Implications for Female Reproduction
Mircea, C. N., Lujan, M. E., & Pierson, R. A. (2007) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32661-5 · Cited by 89
Familial Partial Lipodystrophy (FPLD): Recent Insights
Bagias, C., Xiarchou, A., Bargiota, Α., & Tigas, S. K. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s206053 · Cited by 80
Neuroanatomical Framework of the Metabolic Control of Reproduction
Hill, J. W., & Elias, C. F. (2018) · Physiological Reviews · doi:10.1152/physrev.00033.2017 · Cited by 80
Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy
Oral, E. A., & Chan, J. L. (2010) · Endocrine Practice · doi:10.4158/ep09155.ra · Cited by 77
Chan, J. L., Williams, C. J., Raciti, P., Blakeman, J., Kelesidis, T., Kelesidis, I., Johnson, M. L., Thorner, M. O., & Mantzoros, C. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0056 · Cited by 75
Leptin: A hormone linking activation of neuroendocrine axes with neuropathology
Stieg, M. R., Sievers, C., Farr, O. M., Stalla, G. K., & Mantzoros, C. S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.004 · Cited by 75
von Schnurbein, J., Moss, A., Nagel, S. A., Muehleder, H., Debatin, K. M., Farooqi, I. S., & Wabitsch, M. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336003 · Cited by 70
Neuroendocrine and metabolic effects of adipocyte-derived hormones
Jackson, M. B., & Ahima, R. S. (2006) · Clinical Science · doi:10.1042/cs20050243 · Cited by 68
Adipokines that link obesity and diabetes to the hypothalamus
Ahima, R. S., Qi, Y., & Singhal, N. S. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)53009-2 · Cited by 72
Leptin as a Modulator of Neuroendocrine Function in Humans
Khan, S. M., Hamnvik, O. R., Brinkoetter, M. T., & Mantzoros, C. S. (2012) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.4.671 · Cited by 67
Oral, E. A., Javor, E. D., Ding, L., Uzel, G., Cochran, E. K., Young, J. R., DePaoli, A. M., Holland, S. M., & Görden, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1220 · Cited by 69
Self-citationLungu, A. O., Zadeh, E. S., Goodling, A., Cochran, E. K., & Görden, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1896 · Cited by 65
Self-citationUse of concentrated insulin human regular (U-500) for patients with diabetes
Segal, A. R., Brunner, J. E., Burch, F. T., & Jackson, J. A. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090554 · Cited by 62
Leptin in congenital and HIV-associated lipodystrophy
Tsoukas, M. A., Farr, O. M., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.017 · Cited by 58
Physiology and Disorders of Puberty
Styne, D. M., & Grumbach, M. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00025-3 · Cited by 55
Diagnostic strategies and clinical management of lipodystrophy
Foss‐Freitas, M. C., Akıncı, B., Luo, Y., Stratton, A., & Oral, E. A. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1735360 · Cited by 53
The role of adipokines in relation to HIV lipodystrophy
Sweeney, L. L., Brennan, A., & Mantzoros, C. S. (2007) · AIDS · doi:10.1097/qad.0b013e3280adc91e · Cited by 50
Özen, S., Akıncı, B., & Oral, E. A. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0124 · Cited by 44
Lipodystrophic syndromes: From diagnosis to treatment
Sollier, C., Vatier, C., Capel, É., Lascols, O., Auclair, M., Janmaat, S., Fève, B., Jéru, I., & Vigouroux, C. (2019) · Annales d Endocrinologie · doi:10.1016/j.ando.2019.10.003 · Cited by 44
Leptin therapy for partial lipodystrophy linked to a PPAR‐γ mutation
Guettier, J., Park, J. Y., Cochran, E. K., Poitou, C., Basdevant, A., Meier, M., Clément, K., Magré, J., & Görden, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03095.x · Cited by 42
Self-citationRole of the adipocyte-derived hormone leptin in reproductive control
García-Galiano, D., Allen, S. J., & Elias, C. F. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0017 · Cited by 40
Update on Therapeutic Options in Lipodystrophy
Akıncı, B., Meral, R., & Oral, E. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1100-7 · Cited by 41
Puberty in Non-human Primates and Man
Plant, T. M., Terasawa, E., & Witchel, S. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00032-6 · Cited by 39
Pregnancy in a Woman With Congenital Generalized Lipodystrophy
Maguire, M., Lungu, A., Görden, P., Cochran, E. K., & Stratton, P. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31822cecf7 · Cited by 38
Self-citationThe Changes They are A-Timed: Metabolism, Endogenous Clocks, and the Timing of Puberty
Tolson, K. P., & Chappell, P. E. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00045 · Cited by 37
Stress‐Associated or Functional Hypothalamic Amenorrhea in the Adolescent
LIU, J. H., & Bill, A. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.027 · Cited by 36
Approach to the Patient With Lipodystrophy
Fourman, L. T., & Grinspoon, S. K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac079 · Cited by 35
Brennan, A. M., Lee, J. H., Tsiodras, S., Chan, J. L., Doweiko, J. P., Chimienti, S. N., Wadhwa, S. G., Karchmer, A. W., & Mantzoros, C. S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0597 · Cited by 34
Styne, D. M., & Grumbach, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00025-0 · Cited by 37
Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth
Musso, C., Shawker, T. H., Cochran, E. K., Javor, E. D., Young, J. R., & Görden, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02302.x · Cited by 33
Self-citationRepositioning leptin as a therapy for Alzheimer’s disease
Johnston, J. M., Greco, S. J., Hamzelou, A., Ashford, J. W., & Tezapsidis, N. (2011) · Therapy · doi:10.2217/thy.11.57 · Cited by 32
An overview of lipodystrophy and the role of the complement system
Corvillo, F., & Akıncı, B. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.05.011 · Cited by 31
The role of leptin in fetal growth: A short review from conception to delivery
Grisaru‐Granovsky, S., Samueloff, A., & Elstein, D. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.06.021 · Cited by 30
Role of insulin resistance on fertility – Focus on polycystic ovary syndrome
Vatier, C., Christin‐Maître, S., & Vigouroux, C. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.004 · Cited by 29
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives
Tchang, B. G., Shukla, A. P., & Aronne, L. J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1052789 · Cited by 28
Therapeutic use of recombinant methionyl human leptin
Vatier, C., Gautier, J., & Vigouroux, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.013 · Cited by 29
Use of U-500 insulin in the treatment of severe insulin resistance
Cochran, E. K., & Görden, P. (2008) · Insulin · doi:10.1016/s1557-0843(08)80049-8 · Cited by 27
Self-citationAbel, B. S., Muniyappa, R., Stratton, P., Skarulis, M. C., Görden, P., & Brown, R. J. (2015) · Neuroendocrinology · doi:10.1159/000439432 · Cited by 24
Role of Seipin in Human Diseases and Experimental Animal Models
Li, Y., Yang, X., Peng, L., Xia, Q., Zhang, Y., Huang, W., Liu, T., & Jia, D. (2022) · Biomolecules · doi:10.3390/biom12060840 · Cited by 23
Walzer, D., Turcu, A. F., Jha, S., Abel, B. S., Auchus, R. J., Merke, D. P., & Brown, R. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac365 · Cited by 22
Consequences of Stopping and Restarting Leptin in an Adolescent with Lipodystrophy
Kamran, F., Rother, K. I., Cochran, E. K., Zadeh, E. S., Görden, P., & Brown, R. J. (2012) · Hormone Research in Paediatrics · doi:10.1159/000341398 · Cited by 21
Self-citationPapathanasiou, A. E., Nolen-Doerr, E., Farr, O. M., & Mantzoros, C. S. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0847 · Cited by 20
Impact of gonadotropin administration on folliculogenesis in prepubertal ob/ob mice
Olatinwo, M. O., Bhat, G. K., Stah, C. D., & Mann, D. R. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.003 · Cited by 20
Gambineri, A., & Zanotti, L. (2018) · Nucleus · doi:10.1080/19491034.2018.1509659 · Cited by 19
Ren, M., Shi, J., Jia, J., Guo, Y., Ni, X., & Shi, T. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01383-y · Cited by 20
Leptin Decreases Energy Expenditure Despite Increased Thyroid Hormone in Patients With Lipodystrophy
Grover, A., Quaye, E. M., Brychta, R. J., Christensen, J. D., Startzell, M. S., Meehan, C. A., Valencia, A., Marshall, B. D. L., Chen, K. Y., & Brown, R. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab269 · Cited by 21
Rodríguez, A. J., Neeman, T. M., Giles, A. G., Mastronardi, C. A., & Filho, G. D. P. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003174 · Cited by 17
U-500 Insulin: When More With Less Yields Success
Cochran, E. K. (2009) · Diabetes Spectrum · doi:10.2337/diaspect.22.2.116 · Cited by 17
Self-citationWhat have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN?
Vigouroux, C. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.02.017 · Cited by 17
Metreleptin Treatment in Three Patients with Generalized Lipodystrophy
Musso, C., Major, M. L., Andres, E., & Simha, V. (2016) · Clinical Medicine Insights Case Reports · doi:10.4137/ccrep.s40196 · Cited by 13
Self-citationIuorno, M. J., Islam, L. Z., Veldhuis, P. P., Boyd, D. G., Farhy, L. S., Johnson, M. L., Nestler, J. E., & Evans, W. S. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.027 · Cited by 12
Leptin Therapy in Patients with Lipodystrophy and Syndromic Insulin Resistance
Brown, R. J., & Görden, P. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_18 · Cited by 12
Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment
Gilio, D., Foss‐Freitas, M. C., & Oral, E. A. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01603-4 · Cited by 13
Leptin replacement therapy in the management of lipodystrophy syndromes
Vigouroux, C., Mosbah, H., & Vatier, C. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.05.022 · Cited by 11
Al-Yaarubi, S., Alsagheir, A., Shidhani, A. N. A., Alzelaye, S., Alghazir, N., Brema, I. A., Alsaffar, H., Dubayee, M. A., Alshahrani, A. S., Abdelmeguid, Y., et al. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03084-2 · Cited by 10
The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis
Liu, S.-M., Ifebi, B., Johnson, F., Xu, A., Ho, J., Yang, Y., Schwartz, G. J., Jo, Y., & Chua, S. C. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164185 · Cited by 10
Mosbah, H., Vatier, C., Andriss, B., Belalem, I., Delemer, B., Janmaat, S., Jéru, I., Collen, L. L., Maiter, D. M., Nobécourt, E., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad169 · Cited by 10
Montenegro, R. M., Lima, G. E. D. C. P., Fernandes, V. O., Montenegro, A. P. D. R., Ponte, C. M. M., Martins, L. V., Pinheiro, D. P., de Moraes, M. E. A., de Moraes, M. O., & d’Alva, C. B. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00538-y · Cited by 10
Witchel, S. F., & Plant, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00018-4 · Cited by 10
Treatment Options for Lipodystrophy in Children
Mainieri, F., Tagi, V. M., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.879979 · Cited by 10
Tsoukas, M. A., & Mantzoros, C. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00037-8 · Cited by 10
Adipokines and etiopathology of metabolic disorders
AL-Dokhi, L. M. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4817 · Cited by 9
Leptin and Its Emerging Role in Children and Adolescents
Kelesidis, I., & Mantzoros, C. S. (2006) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.15.1 · Cited by 8
Metreleptin treatment of non-HIV lipodystrophy syndromes
Chevalier, B., Lemaître, M., Leguier, L., Mapihan, K. L., Douillard, C., Jannin, A., Espiard, S., & Vantyghem, M. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104070 · Cited by 8
Costa, S. T. B., Sampaio, L., Sousa, A. B., Xing, C., Agarwal, A. K., & Garg, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac406 · Cited by 7
Insulin Receptor and its Relationship with Different Forms of Insulin Resistance
Rojek, A., & Niedziela, M. (2010) · Postepy Biologii Komorki · doi:10.2478/v10052-010-0004-8 · Cited by 7
The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction
Görden, P., & Park, J. Y. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600736117 · Cited by 7
Congenital Generalized Lipodystrophy
Lima, J. G. (2018) · Journal of Rare Diseases Research & Treatment · doi:10.29245/2572-9411/2018/2.1147 · Cited by 6
Metadata
- Authors
- Musso, C., Cochran, E., Javor, E., Young, J., DePaoli, A. M., & Gorden, P.
- Affiliations
- National Institutes of Health (US)
- Amgen (United States) (US)
- Corresponding author
- Musso, Carla
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 54
- Issue
- 2
- Pages
- 255-263
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2059105920
- Semantic Scholar
- 9facc3ba9dec2ca44742978285cee6875b5d0fc5
- Cited by
- 146
- References
- 32
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 11 · 2013: 4 · 2012: 8
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- lipodystrophy, hypoleptinemia, hyperandrogenism, polycystic ovary syndrome, amenorrhea, menstrual function, luteinizing hormone, sex hormone-binding globulin, testosterone, insulin resistance, insulin-like growth factor, pituitary function, glycemic control, hypoglycemia, puberty
- MeSH terms
- Adolescent, Adult, Aged, Amenorrhea, Androgens, Blood Glucose, Child, Female, Humans, Insulin-Like Growth Factor I, Luteinizing Hormone, Lipodystrophy, Male, Menstruation, Pituitary Function Tests, Pituitary Gland, Polycystic Ovary Syndrome, Puberty, Recombinant Proteins, Sex Hormone-Binding Globulin, Testosterone, Thyroid Gland, Hyperandrogenism, Human Growth Hormone, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
